IP Library Granted Patent US 10,174,087
Granted Patent B2
US 10,174,087 · App. 15/299,457 · Granted Jan 8, 2019

Enhanced productivity by attenuation of chlorophyll binding protein genes

Inventors: Jonathan E. Meuser (Fort Myers, FL); Christen G. DiPetrillo (Santa Clara, CA); Jay McCarren (Cardiff, CA); Shaun Bailey (San Diego, CA)
Assignee: Synthetic Genomics, Inc.
C07K14/405C12N1/12C12N15/113C12N15/902C12N2800/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,174,087
App. No.
15/299,457
Granted
Jan 8, 2019
Kind
B2
Abstract

Mutant photosynthetic algae having increased biomass productivity are provided. The mutants have attenuated expression of violaxanthin chlorophyll a binding proteins (VCP) or fucoxanthin chlorophyll a/c binding proteins (FCP), reduced chlorophyll, higher apparent ETR(II), little to no reduction in P max per cell, and decreased NPQ over a wide range of light intensities. Provided herein are constructs for attenuating or disrupting VCP or FCP genes. Also provided are methods of culturing VCP or FCP mutants for the production of biomass or other products.

Claims (13)

1. A recombinant or classically-mutagenized Nannochloropsis alga that has attenuated expression of at least one violaxanthin chlorophyll a-binding protein (VCP) gene.

2. The recombinant or classically-mutagenized mutant Nannochloropsis alga of claim 1 , wherein expression of all VCP genes of the alga are attenuated.

3. The recombinant or classically-mutagenized mutant Nannochloropsis alga of claim 1 , wherein the amount of RNA transcribed by all of the VCP genes in the mutant alga is less than 10% of the amount of RNA transcribed by all of the VCP genes in a control alga.

4. A recombinant or classically-mutagenized Nannochloropsis alga according to claim 1 , wherein the alga has at least one disrupted VCP gene.

5. The recombinant or classically-mutagenized Nannochloropsis alga of claim 4 , wherein all VCP genes of the alga are disrupted.

6. The recombinant or classically-mutagenized Nannochloropsis alga of claim 4 , wherein the at least one VCP gene is disrupted by insertional mutagenesis.

7. The recombinant or classically-mutagenized Nannochloropsis alga of claim 4 , wherein the at least one gene is disrupted by deletion of all or a portion of one or more VCP genes.

8. The recombinant or classically-mutagenized Nannochloropsis alga of claim 4 , wherein the at least one gene is disrupted by homologous recombination.

9. The recombinant or classically-mutagenized Nannochloropsis alga of claim 4 , wherein the at least one gene is disrupted by CRISPR RNA-guided nuclease activity.

10. The recombinant or classically-mutagenized Nannochloropsis alga of claim 1 , wherein the mutant alga exhibits a higher Electron Transport Rate (ETR) than a control alga substantially identical to the mutant alga with the exception that the control alga does not have attenuated expression of at least one VCP gene.

11. The recombinant or classically-mutagenized Nannochloropsis alga of claim 1 , wherein the mutant alga exhibits lower Non-Photochemical Quenching (NPQ) induction than a control alga substantially identical to the alga with the exception that the control alga does not have attenuated expression of at least one VCP gene.

12. The recombinant or classically-mutagenized Nannochloropsis alga of claim 1 , wherein the chlorophyll content of the mutant algal is reduced by at least 15% on a per cell basis.

13. The recombinant or classically-mutagenized Nannochloropsis alga of claim 1 , wherein the mutant alga has increased biomass productivity with respect to a control alga that does not have attenuated expression of at least one VCP gene.

Assignments (4)
CHANGE OF NAME Recorded Apr 7, 2022
From: SYNTHETIC GENOMICS, INC.
To: VIRIDOS, INC.
Reel/Frame 059631/0684 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2020
From: OXFORD FINANCE LLC
To: SYNTHETIC GENOMICS, INC.; GENOVIA BIO, LLC; GREEN RESOURCES, LLC; SGI-DNA, INC.; SYNTHETIC GENOMICS VACCINES, INC.
Reel/Frame 054372/0822 →
SECURITY INTEREST Recorded Mar 20, 2019
From: SYNTHETIC GENOMICS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 048655/0406 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2016
From: MEUSER, JONATHAN E.; DIPETRILLO, CHRISTEN G.; MCCARREN, JAY; BAILEY, SHAUN
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 040394/0213 →
Continuity (2)
Provisional Application 62244079 · Oct 20, 2015
Related Publication 20170114107A1 · Apr 27, 2017